Conventional rheumatoid arthritis treatments focus on slowing disease progression and managing symptoms. However, they often fall short of addressing the root cause of the disease or promoting true recovery. Our approach goes beyond traditional therapies by leveraging extracellular vesicles (EVs) from mesenchymal stem cells to potentially repair damaged tissue and restore normal joint function.

By advancing beyond symptom management, we aim to not only halt disease progression but also reverse its impact, offering patients a path to improved functionality and long-term relief. Our innovative platform provides a foundation for developing scalable, standardized therapies that could reshape rheumatoid arthritis treatment for the future.